National research released this week highlights a concerning trend: endometrial cancer, the most common form of uterine cancer, is being diagnosed more frequently in women under 50. The study, conducted by the National Institutes of Health, examined cancer incidence from 2010 to 2019 and found that rates for 14 cancer types, including uterine cancer, rose among younger adults.
Why Age Should Not Delay Care
Doctors stress that abnormal vaginal bleeding is the key warning sign, even for women who are not yet menopausal. “Heavy bleeding or any bleeding after a year without periods should prompt a medical visit,” said Dr. Lindsey McAlarnen, a gynecologic oncologist at Nebraska Medicine. She has observed an uptick in patients in their 20s, 30s, and 40s facing this diagnosis.
One such patient, 43‑year‑old Amy Nissen, experienced unusually heavy bleeding in March 2024. “It was the heaviest bleeding I’d ever had,” she recalled. After weeks of embarrassment and delayed medical attention, Nissen sought care in an emergency department and was diagnosed with endometrial cancer just before her birthday.
Statistics and Risk Factors
The NIH report estimates roughly 62,000 new cases of endometrial cancer were diagnosed in the United States in 2025, resulting in about 12,500 deaths. While obesity remains a significant risk factor and can increase the chance of cancer recurrence, Dr. McAlarnen emphasized that the disease can affect women without any known risk factors.
Early detection dramatically improves outcomes. When caught at stage one, survival rates exceed 95 %. Conversely, once the cancer spreads, the prognosis worsens considerably.
Patient Stories Highlight the Message
Nissen’s case illustrates the importance of timely evaluation. She opted for a total hysterectomy, a surgery that removes the uterus, and has recovered well without needing chemotherapy. “I wish I had spoken up sooner,” she said, hoping her story will encourage other women to break the stigma surrounding reproductive‑health conversations.
Dr. McAlarnen and Nissen are collaborating with GSK on a “Don’t Be Embarrassed” campaign aimed at normalizing discussions about abnormal bleeding and other reproductive symptoms. The initiative encourages women to approach their health care providers without fear.
Practical Guidance for Women
Medical experts recommend that any woman experiencing heavy bleeding, unexpected discharge, or persistent pelvic pain seek evaluation promptly. Post‑menopausal women should be especially vigilant; any bleeding after a year without periods warrants immediate attention.
Women should also discuss hormone use—whether oral contraceptives, topical treatments, or other estrogen‑containing products—with their doctors, as excess estrogen can raise the risk of endometrial cancer in certain circumstances.
Looking Ahead
While the rise in diagnoses is unsettling, the emphasis on early detection and patient education offers a path forward. By fostering open dialogue and encouraging prompt medical assessment, health professionals aim to keep survival rates high and reduce the overall burden of this disease.
Original reporting: WOWO News/Talk (Fort Wayne) — read the source article.
